Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Posts with tag medication
Posted Jun 26th 2007 6:00AM by Kristina Collins
Filed under: Drug, All Cancers, Research, Thought for the Day
Reaching for the first sleep aid you find when insomnia hits? Not all sleeping pills are the same. Each class of sleep aid works a bit differently from the other, and side effects vary.
It's important to ask key questions before choosing your sleep medicine.
- How long does it take for the sleeping pill to take effect?
- How long do the effects last?
- What's the risk of becoming dependent on the sleeping pill, physically or psychologically?
All sleep medicines have the potential for causing dependence. In the large majority of cases, however, this is psychological dependence, not physical.
Talk with your doctor, and use this chart to help you decide which sleeping pill is right for you.
Posted Jun 10th 2007 8:00AM by Kristina Collins
Filed under: All Cancers, Sunday Seven, Surgery
When you're diagnosed with cancer, most likely you will receive some kind of surgery. Usually, your physician has a list of care instructions for you to prepare before surgery.
What about after-surgery preparations? When you return home it can really make you feel better if you are well prepared. You'll thank yourself for the steps you take beforehand while you're recuperating.
Seven ways to prepare for after surgery:
- Take care of any pressing issues so you won't have to deal with them when you come home from the hospital. For example, pay bills that are due. You also might want to pay some bills that are due at a later date, or just get them ready to mail out.
- Go to the grocery store and stock up on food. Hopefully someone will be catering to your every need but its always good to have a plan B.
- Get prescriptions filled ahead of time that will be needed after surgery. Sometimes you only get the prescriptions after the surgery is over, but you can ask you doctor to give you what you need ahead of time. You don't want to be waiting in line for your drugs when you're in pain and just out of the hospital.
- Treat yourself to some special things that you like. Examples: Aromatherapy candles, soothing music or videotapes/DVD's to watch.
- If you like to read, buy some books to give you something to do when you're less active. If you have another hobby that you enjoy, stock up on that too.
- Catch up on household chores so you won't feel stressed out and can relax when you return home.
- Accept help that others offer. Plan to rest as you need and don't push yourself.
Posted Apr 11th 2007 10:00AM by Jacki Donaldson
Filed under: Drug, Research, Daily news

The Food and Drug Administration (FDA) will take an additional three months to review Wyeth's kidney cancer drug Torisel -- the first of five new medications the company plans to introduce this year.
The FDA needs more time to investigate data on tumor growth in patients taking Torisel. If all goes well, the drug will be one of only three to effectively hold off incurable kidney cancer. The other two drugs are Pfizer's Sutent and Bayer AG's Nexavar.
Robert Ruffolo, president of Wyeth Research, says he is encouraged by the review process so far. And he is optimistic about launching the product in late 2007.
Studies show Torisel, which will cost patients about $30,000 per year, prolonged survival by 50 percent in those faring poorly with kidney cancer. The sickest kidney-cancer patients were essentially kept alive for 10.9 months, compared with 7.3 months with interferon drugs. Torisel also postponed tumor growth for 5.5 months. This is 77 percent longer than with interferon.
Sutent and Nexavar, both on the market since last year, also slow tumor growth. All three kidney-cancer medicines are of the variety that block the growth of cancer cells -- different from standard chemotherapy which kills tumors and harms nearby tissues too.
Wyeth is relatively new to the oncology market. And soon, the company hopes to launch three more cancer drugs. One, called CMC-544, treats non-Hodgkin's lymphoma. Another, SKI-606, is for chronic myelogenous leukemia. And the third, HKI-272, is for breast cancer.
About 51,000 Americans will be diagnosed with kidney cancer this year.
Posted Apr 6th 2007 9:00AM by Jacki Donaldson
Filed under: All Cancers, Clinical Trials, Products, Daily news, Thought for the Day

I never would have predicted it -- that a tooth could become a tool for dispensing medication. But the refinement of such a creation is actually in the works and before long, you may be asking not for a gold or decorative tooth but for one capable of doling out your drugs in the exact doses and at the right times.
Think about this:
Researchers from Europe and Israel are working right now on a tiny dispensing system called IntelliDrug. Their goal is to create parts small enough they can fit into a false tooth placed in the back of the mouth. The device will release a specific amount of medication at certain intervals so patients receive the proper dosage right on schedule.
This invention, crafted by an Israeli dentist, could pick up the slack for people who forget to take medicine and could save lives for those whose lives depend on scheduled drug therapy. It could also allow for better absorption of medication into the body.
The IntelliDrug device will deliver medicine directly into the bloodstream through the lining of the cheek around the mouth. Saliva, meanwhile, mixes with the drug and carries it throughout they body in a manner more efficient than just swallowing a pill every few hours.
While researchers hope to one day turn their device into a replacement tooth, the apparatus -- consisting of a stainless steel housing, a pump, custom valves, a microprocessor, batteries, and a reservoir for the drug pill -- currently comes in the form of a block the size of two teeth. It is strapped to the the side of teeth and hugs the inside of the cheek. The unit can be removed, and a technician can refill the drug reservoir, clean the unit, and change batteries when necessary.
Clinical trials on pigs are ongoing. Human testing is expected to begin by the end of the year.
Posted Mar 10th 2007 9:00AM by Jacki Donaldson
Filed under: Breast Cancer, All Cancers, Opinion, Magazines, Thought for the Day

My gut hasn't always guided me through life's most difficult decisions and dilemmas. It wasn't until I felt a lump in my breast more than two years ago that my gut kicked into gear and told me something very important.
"It's cancer," my insides told me one week before the surgeon who did my biopsy called.
"It's cancer," the surgeon said. I didn't tell him, but I thought it: "I know."
I also knew prior to surgery that my cancer had not spread to my lymph nodes. My gut told me this too. It also told me the chemotherapy drug Taxol was not right for me -- since my cancer had not spread -- despite the urging of one oncologist that I accept this treatment. I would have gone on gut instinct alone in my rejection of this medication but another doctor weighed in and agreed with my gut, so I had solid backing on this decision.
Many have dismissed hunches like these and have written off those who believe in them as screwballs, says writer Chip Brown in the March 2007 issue of
The Oprah Magazine. But as Brown shares after peering into the world of gut instinct, there are 100 million nerve cells in the gut. They run on autopilot, regulate digestion, play a critical role in the body's immune system, and control mood-altering neurotransmitters identical to those in the brain.
The gut is essentially a second brain. It was a "gut feeling" that led Fred Smith, founder of Federal Express, to begin exploring the possibilities of overnight delivery and Howard Schultz, founder of Starbucks, to begin mass marketing coffee. Wall Street professionals make millions on their gut feelings, sportscasters make startling predictions based on gut guidance, and entrepreneurs launch thriving businesses because of the inklings that rumble in their tummies.
You may or may not be a gut thinker yourself. But I've stumbled upon a gut exercise -- thanks to psychotherapist Nancy Napier --and I'd like for you to consider it the next time you find yourself stuck at a crossroads, unsure of where to turn. You never know, the direction you seek may be swirling around in your midsection, just waiting for a call to action.
Think about this:
You are wavering between two choices. Find yourself a quiet, serene place where there will be no disruptions. Now sit down. Take a moment to settle and focus on the issue you want to explore. Then choose one side. Think about this side and notice what happens in your gut. Do you feel a tightening and gripping or a softening and warming? Are the sensations pleasant or uncomfortable? Notice your thoughts. Are they positive or negative? Give yourself some time to feel your gut and your mind responding.
Now shift to the other side. Think about the previous questions, and try to chart what your body gut is saying.
While you may not get a gut answer at first, if you come back with the question several times, you'll likely hear just what your gut wants you to know.
Posted Feb 25th 2007 10:00AM by Jacki Donaldson
Filed under: Breast Cancer, Chemotherapy, Daily news
North Carolina State women's basketball coach Kay Yow is still in the game, despite her difficult match-up with a fierce opponent -- breast cancer.
Yow is fighting for the third time a disease that has been spreading throughout her body since last fall. She has sores in her mouth, hasn't been able to eat, and receives regular doses of pain medication, antibiotics, and nutrients to combat the effects of three chemotherapy drugs that are cycling through her tired body.
Still, Yow is never far from the sidelines.
She was right there in the mix the day NC State named its women's basketball court in her honor. Shortly after, she was wheeled off the court on a stretcher, headed for the hospital so she could be pumped full of drugs. She was at work the next day. And at the unveiling of the Kay Yow Court. And at her game that same night. And at the end of the night, with an oncologist and nurse, she was accompanied to her office where she was once again hooked up to an IV so drugs could once again drip into Yow's exhausted body.
Yow, 65, is tough and determined.
"I know people are saying I'm doing too much," Yow says. "I know I have to take care of myself. But it's not like I have a cold or pneumonia and if I rest it will get better. Rest is not going to cure cancer. If rest were just the answer, that's what I would do."
"But if someone can be involved with something that is a passion for them, then I don't think there's anything wrong in trying to do that. Coaching lifts me up. Once the ball is tossed up, I forget pretty much about everything and just focus on the game. If I just do nothing, I feel like I'm giving in to the disease."
For anyone keeping score on the battle between Yow and cancer, it's clear Yow is a winner.
Previous posts about Kay Yow are as follows:
NC State coach takes leave to fight breast cancer
NC State basketball coach Kay Yow back in the game
Posted Jan 13th 2007 11:00AM by Jacki Donaldson
Filed under: All Cancers, Products

I used a written journal and then a blog to record the stops along my cancer journey. I kept a file for financial paperwork, and I made lists of questions in anticipation of medical appointments. I saved all prescription instructions to track the abundance of drugs entering my body, and I earmarked a large white cardboard box as my cancer treasure chest. The contents of this box include cards, gifts, newspaper clippings, books, literature, and more. It's practically spilling over with
stuff -- the stuff of cancer.
My system -- which may seem a bit unorganized and splintered -- worked well for me as I tried to keep my head above water following my cancer diagnosis. For others, a more central system may work -- a system that incorporates all pertinent information in one convenient location.
The
LIVESTRONG™ Survivorship Notebook, offered by the Lance Armstrong Foundation, is one option for those seeking a clean, concise way to manage the details of cancer. It's designed to organize and guide. It's portable. It's available for the cost of shipping and handling only. And it includes the following:
Survivorship Tools -- this section includes a personal health journal, an appointment diary, a list for medications, a summary section for health and financial information, and a medical history and treatment area.
Survivorship Stories -- this section features stories of cancer survivors that will inspire and empower.
Survivorship Topics -- this section offers readings, answers to questions, and resources about physical, emotional, and practical issues related to cancer.
This yellow notebook -- a symbol of one man's fight and victory against a mighty disease -- could be the perfect accessory for someone facing the unknown. Sometimes all it takes is a bit of organization to calm nerves, minimize anxieties, soothe fears, and instill a sense of control over an otherwise uncontrollable journey.
Posted Jan 7th 2007 11:00AM by Jacki Donaldson
Filed under: Breast Cancer, Research, Environment, Daily news

The ABC building in the Brisbane suburb of Toowong -- subject of a December 2006
post -- has been officially vacated following an investigation that turned up a cancer cluster among female employees.
Over the past 11 years, 10 women from this one building have been diagnosed with breast cancer. Eight of the women worked in the ABC newsroom, and most had been there for more than five years. The breast cancer risk for these women was six times higher than for the general population of women in the area. And while the investigation continues and clues are beginning to connect, the big question --
Why? -- has still not been answered.
It has been determined it is highly unlikely the increase in breast cancer was caused by exposure to radio frequency, low frequency electromagnetic radiation, or chemical contamination. According to experts, had any of these factors been at play, there would have been a rise in cancer among male employees as well as female employees. Therefore, it appears something specific to women has caused this cluster.
Perhaps clues will emerge from an analysis of lifestyle influences -- like smoking, diet, and alcohol and medication use -- and already women have answered questions pertaining to body weight, height, level of physical activity, and reproductive history.
One common theme among women is the use of oral contraceptives for periods varying from two to 18 years. Other interesting findings include the average number of babies born to the women -- 1.6 -- and the breastfeeding practices of the women -- each woman with a child breastfed for an average of 2.3 to 12 months -- and the educational background of the group -- of the 10 women, six have college degrees.
Experts says these are important factors. Early puberty, late menopause, lack of breastfeeding, use of oral contraceptives, and the trend of older mothers having fewer babies all can influence breast cancer risk. And so can level of education. Research shows increased rates of breast cancer in women with white collar jobs -- which is related to socioeconomic status and late childbearing.
Everything is important really -- because as breast cancer rates continue to skyrocket, all possible reasons need to be considered.
One in eight women in Australia will be diagnosed with breast cancer before the age of 85. About 13,261 women were diagnosed with breast cancer in 2006. And it is predicted that 14,818 will be diagnosed in 2011.
Posted Dec 28th 2006 3:40PM by Kristina Collins
Filed under: Drug, Chemotherapy, Prevention, All Cancers
Zofran (Ondansetron) tablets are used to prevent nausea and vomiting associated with chemotherapy. I remember Zofran costing about $30 a tablet back in 2002 when I was receiving chemotherapy. I was lucky I had insurance that covered the high cost of the drugs I needed. Yesterday the Food and Drug Administration approved the first generic versions of Zofran.
Gary j. Buehler, director, Office of General Drugs, says "This approval will result in significant savings for the American public. Generic drugs are safe and effective alternatives to brand name drugs and undergo a thorough scientific and regulatory review".
Generic drugs usually cost a fraction of the price of the brand-name drugs.
Posted Dec 26th 2006 9:00AM by Jacki Donaldson
Filed under: Research, Daily news

Kidney transplants can save lives. They can also increase the risk of developing a variety of cancers, according to Australian researchers who report a risk 300 percent higher than in the general population.
Most cancers developed in kidney transplant patients have a known or suspected viral origin, suggesting the weakened immune systems in these patients limit protection against cancer.
"The immunosuppressive drugs transplant patients take lower their ability to fight off infections that can trigger malignancy", the lead researcher said. "We believe the increased incidence of infection leads to the infection that results in cancer." She also notes there is probably an even greater risk of cancer among heart and lung transplant patients because these patients receive more powerful immunosuppressive drugs.
Researchers gathered their findings by comparing the incidence of cancer in 29,000 patients with end-stage kidney disease who received kidney transplants. Data was collected beginning five years prior to transplantation, during dialysis, and after transplantation. Researchers then consulted an Australian registry to identify cancers occurring between the years of 1982-2003. They compared the statistics with the number of cancers seen among transplant patients.
These cancers included melanoma, Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, leukemia and cancers of the lip, tongue, mouth, salivary gland, esophagus, stomach, colon, anus, liver, gallbladder, lung, connective and other soft tissue, vulva, cervix, penis, eye and thyroid. There was also an increase in nasal cavity and vaginal cancers.
This study has important implications for future immosuppression. Patients should give considerable thought to quality-of-life transplants -- such as face transplants and hand transplants -- and should carefully weigh the risks of weakened immunity. On a brighter note, this study might help prompt research on medication that can selectively target the part of the body responsible for rejecting a transplant. Because right now, medications affect the entire immune system -- and this is what makes patients more prone to developing cancer.
Posted Dec 19th 2006 10:00PM by Dalene Entenmann
Filed under: Drug, Chemotherapy, Pancreatic Cancer, Clinical Trials, Research

Pancreatic cancer is considered one of the most deadly of cancers. The statistics are grim, as 95 percent of patients diagnosed with pancreatic cancer do not survive, and 50 percent of patients die within six months after the cancer is diagnosed. There might be some hope in an allergy medication that has been around for 40 years.
According to University of Texas M. D. Anderson Cancer Center researchers, the allergy medication
cromolyn reduced pancreatic tumor growth in mouse model studies, and when the drug was combined with the chemotherapy drug gemcitabine, the standard chemotherapy treatment was three times more effective. They are reported to be in the process of starting a clinical trial.
The study's lead author, Craig Logsdon, Ph.D. is quoted as saying, "The study demonstrates in mouse models of human pancreatic cancer that the cromolyn-gemcitabine combination reduced cancer growth by 85 percent compared to control animals. Cromolyn used alone actually had a good effect on reduction of tumors compared to control animals, which surprised us. It reduced tumor growth by 70 percent, compared to growth reduction of 50 percent when gemcitabine was used as a single agent."
"Our goal is to offer longer life to these patients, and the combination of these two agents may well do that."
To learn more about pancreatic cancer, visit the
pancreatic cancer category here and the National Cancer Institute's
What You Need To Know About Cancer of the Pancreas.
Posted Dec 18th 2006 9:00AM by Jacki Donaldson
Filed under: Breast Cancer, Research, Daily news
Before 2002, hormone replacement therapy (HRT) was believed to prevent many conditions, and doctors routinely prescribed hormone pills. But when a 2002 study found HRT raises the risk of breast cancer, heart disease, and other problems, the use of hormones plummeted.
On Thursday, researchers reported that the rate of breast cancer cases in the United States dropped more than seven percent in 2003 -- the year after the landmark study that caused a backlash against hormones. This backlash is considered the leading cause for the now-reported decline in breast cancer cases.
Now, even more women are expected to abandon the pills. And doctors worry that women with severe menopausal symptoms -- who need the treatment -- will deny themselves the benefits hormones can offer.
There are ways to take advantage of the benefits, however, and still minimize the risks. One gynecology group shares the following suggestions.
- Take the lowest dose for the shortest time -- two or three years if possible. Start out small and add more medication if symptoms do not decrease.
- Do not take hormones to try to prevent heart disease -- because they do not prevent it.
- Never take estrogen without progestin if you still have a uterus. This raises the risk of uterine cancer.
- Try periodically to cut your dose and wean yourself off.
For those who don't definitively need hormone therapy, it's important to discontinue use. But some women truly do need the treatment and should not abruptly stop their therapy in light of news that is not definitive in itself. As always, consultation with a physician is the best first step.
Previous posts on the topic of HRT and breast cancer are as follows.
Posted Dec 9th 2006 12:00PM by Kristina Collins
Filed under: Drug, Pancreatic Cancer, Research

Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found that some blood pressure medications might help stop the spread of pancreatic cancer. ACE inhibitors and AT1R blockers may inhibit angiogenesis, the development of blood vessels that feed a tumor.
A pancreatic hormone called angiotensin II (Ang II) has shown in previous studies to be repressed by the use of either an ACE inhibitor or AT1R blocker. The hormone Ang II increases the production of vascular endothelial growth factor (VEGF). VEGF is a substance made by cells that stimulate new blood vessel formation (angiogenesis). It is one of the most important endothelial growth factors and also helps regulate angiogenesis. VEGF is known to promote blood vessel growth in a number of cancers. High VEGF levels has been associated with a poor prognosis and earlier recurrence of cancer.
The researchers examined normal and malignant pancreatic tissue. Captopril, an ACE inhibitor and losartan, an AT1R blocker stopped the effect that Ang II had on VEGF production. The research showed that both ACE and AT1R protein found in the pancreas was 75 percent higher in the malignant tissue and VEGF was higher in these same tissue samples.
Dr. Hwyda Arafat, M.D., Ph.D., assistant professor of surgery at Jefferson Medical College, said "Our data show for the first time that both ACE and AT1R are functionally expressed in pancreatic adenocarcinoma and suggest their involvement in tumor angiogenesis. High levels of Ang II might mean high levels of VEGF and pancreatic cancer. We have a treatment to block it."
Posted Oct 22nd 2006 10:00AM by Jacki Donaldson
Filed under: All Cancers, Sunday Seven

I have a new friend who is a new breast cancer survivor. She is surviving a new diagnosis, a recent lumpectomy, and the moments leading up to another surgery to further investigate the margins surrounding the tumor removed from her breast. She is surviving the first phase of her breast cancer journey. A phase full of uncertainty and fear and panic. A phase so new and so fresh and so raw, her mind is whirling. A phase that has her grasping for any bit of direction she can find as she navigates a terrifying, unfamiliar road.
My friend is a young wife and mother whose worries are consuming her. She e-mailed me today and asked if I ever have moments when I look at my young children and worry that cancer will take me from them while they are young. She asked if I have always been so sure I will be okay. And so I replied with this candid cancer confession.
Continue reading Sunday Seven: Seven completely candid cancer confessions
Posted Oct 10th 2006 1:20PM by Kristina Collins
Filed under: Drug, Chemotherapy, Prevention, All Cancers
Before I had my first chemotherapy treatment I was told that to prevent from getting nauseous and vomiting as a side effect that I could take a pill. I mean, what is worse than being nauseous all the time? Not too many things. I was prepared after my first chemotherapy of Adriamycin and Cytoxan to be leaning over the toilet for a long time. This vision was what I expected to happen and I tried to be ready for it knowing that the anti-nausea drugs given aren't always effective for everyone. I did end up spending a lot of time near the toilet after taking Zophran, an anti-nausea medication, but I spent that time on the toilet, not leaning over it!
Continue reading Chemotherapy and anti-nausea medication
Next Page >